Oxford BioTherapeutics and Roche to Research on Novel Targets for Antibody-Based Therapeutics
OBT’s recently launched enhanced proprietary OGAP®-Verify discovery platform enables greater sensitivity and thereby the selection of targets with improved attributes for drug development.
Antibody-Based Therapeutics | 25/03/2025 | By Aishwarya
GC Biopharma Partners with Novelty Nobility to Jointly Research for Geographic Atrophy Therapies
Under the terms of the agreement, GC Biopharma and Novelty Nobility established a partnership to jointly research and develop antibody-based protein therapeutics for GA throughout all stages of the drug development lifecycle.
Antibody-based Therapeutics | 28/10/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy